# K021874: Abbott Q2 Plus S02/Continuous Cardiac Output Computer, List Number 56711

- Pathway: 510(k) (Traditional)
- Applicant: Abbott Laboratories
- Decided: Jul 12, 2002 after 35 days
- Product code: DXG (Computer, Diagnostic, Pre-Programmed, Single-Function)
- Device class: 2
- Regulation: 21 CFR 870.1435
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K853018 (1986). 2 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K853018: Model 3000 Opticath Computer, Oximetrix, Inc. (1986) Summary page 1.
- K932414: Continuous Cardiac Output System, Abbott Laboratories (1994) Summary page 1.

## Most influential descendants
- K152006: Cogent Hemodynamic Monitoring System (2016), 1 descendant of its own
- K232048: Cogent™ Hemodynamic Monitoring System; Cogent™ HMS (2023), 0 descendants of its own

## Indications for use
The Abbott Q2TMPlus S02/Continuous Cardiac Output Computer has the following indications for use: It is intended for deriving and monitoring hemodynamic and cardiac parameters in patients with pre-existing central line access. It monitors cardiac output, body core temperature and blood oxygen saturation. These and other calculated hemodynamic values are displayed and may be communicated to other external monitoring systems. It is intended to be used in medical and surgical intensive care units, operating rooms, trauma and accident emergency units, coronary and intensive care units and cardiac catheterization laboratories.

Source page: https://510kreport.com/device/K021874
Methodology: https://510kreport.com/methodology